Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China
- PMID: 37051708
- DOI: 10.1089/thy.2022.0460
Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China
Abstract
Objective: Gestational transient thyrotoxicosis (GTT) and Graves' disease (GD) are the most common causes of hyperthyroidism during pregnancy. However, few studies have compared pregnancy outcomes of patients who had GTT with those who had GD in the first trimester of pregnancy. Methods: We conducted a prospective multicenter cohort study in China. Participants received questionnaires, physical examinations, and underwent measurements of thyrotropin (TSH), free thyroxine (fT4), thyroid peroxidase antibody (TPOAb), TSH receptor antibody (TRAb), and urinary iodine in the first trimester. The patients diagnosed with either GTT or GD and normal thyroid function (NTF) group were followed until delivery. The thyroid function and pregnancy outcomes were reported. Results: A total of 125 pregnant women with thyrotoxicosis and 246 age-matched pregnant women with NTF were included. (1) The thyroid function of the GTT group returned to normal range in the third trimester, but was consistently abnormal in the GD group. (2) The incidence of gestational diabetes mellitus (GDM) in the GTT group (11.5%, 9/78) was significantly higher than that in NTF group (4.9%, 12/246) (p = 0.037). The incidence of premature delivery in the GD untreated (30.8%, 8/26, p = 0.002) and treated groups (28.6%, 6/21, p = 0.008) was both, respectively, higher than that in the NTF group (7.7%, 19/246). Miscarriage (15.4%, 4/26 vs. 3.7%, 9/246, p = 0.026) and gestational hypertension (19.2%, 5/26 vs. 3.3%, 8/246, p = 0.004) were more prevalent in the GD untreated group than in the NTF group. (3) The presence of positive TRAb and positive TPOAb in the first trimester were independent risk factors for miscarriage (odds ratio [OR] = 5.23, confidence interval [CI] = 1.11-24.78, p = 0.037) and low birth weight infants (OR = 7.76, CI = 1.23-48.86, p = 0.029), respectively. Conclusion: In conclusion, pregnancy outcomes appear variable, according to the etiology of first trimester thyrotoxicosis. GTT appears to be associated with GDM. GD appears to be associated with an increased risk of premature delivery, gestational hypertension, and miscarriage. The diagnosis of GTT and GD patients during early pregnancy and appropriate treatment of GD patients may be associated with improved pregnancy outcomes.
Keywords: Graves' disease; gestational and postpartum complications; gestational transient thyrotoxicosis; maternal thyrotoxicosis.
Similar articles
-
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.Thyroid. 2007 Aug;17(8):767-72. doi: 10.1089/thy.2007.0003. Thyroid. 2007. PMID: 17651013
-
[Effect of the treatment acceptance on the perinatal outcomes in women with subclinical hypothyroidism, positive thyroid gland peroxidase antibody in early pregnancy].Zhonghua Fu Chan Ke Za Zhi. 2015 Sep;50(9):652-7. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 26675390 Chinese.
-
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?Endocr J. 2015;62(6):557-60. doi: 10.1507/endocrj.EJ14-0596. Epub 2015 Mar 29. Endocr J. 2015. PMID: 25819223
-
Pitfalls in the assessment of gestational transient thyrotoxicosis.Gynecol Endocrinol. 2020 Aug;36(8):662-667. doi: 10.1080/09513590.2020.1754391. Epub 2020 Apr 17. Gynecol Endocrinol. 2020. PMID: 32301638 Review.
-
Thyroid hyperfunction during pregnancy.Thyroid. 1998 Sep;8(9):859-64. doi: 10.1089/thy.1998.8.859. Thyroid. 1998. PMID: 9777758 Review.
Cited by
-
Pregnancy outcome following radioactive iodine therapy for Graves' disease in women of childbearing age: a systematic review.Thyroid Res. 2025 Jun 12;18(1):26. doi: 10.1186/s13044-025-00242-x. Thyroid Res. 2025. PMID: 40500752 Free PMC article. Review.
-
Independent risk factors for placental abruption: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2025 Mar 26;25(1):351. doi: 10.1186/s12884-025-07482-7. BMC Pregnancy Childbirth. 2025. PMID: 40140972 Free PMC article.
-
Gestation-suppressed serum TSH levels during early pregnancy are not associated with altered maternal and neonatal outcomes.Eur Thyroid J. 2023 Oct 18;12(6):e230112. doi: 10.1530/ETJ-23-0112. Print 2023 Dec 1. Eur Thyroid J. 2023. PMID: 37855409 Free PMC article.
-
Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.Endocrine. 2024 May;84(2):500-508. doi: 10.1007/s12020-023-03569-3. Epub 2023 Oct 20. Endocrine. 2024. PMID: 37861945
-
Controversies in thyroid disease management in pregnancy.Clin Med (Lond). 2025 Jan;25(1):100287. doi: 10.1016/j.clinme.2025.100287. Epub 2025 Jan 17. Clin Med (Lond). 2025. PMID: 39826831 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical